Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy
Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy
About this item
Full title
Author / Creator
Publisher
Cambridge, UK: Cambridge University Press
Journal title
Language
English
Formats
Publication information
Publisher
Cambridge, UK: Cambridge University Press
Subjects
More information
Scope and Contents
Contents
The impact of controlled administration of Bifidobacterium animalis subsp. lactis BB-12 (BB-12) on the risk of acute infectious diseases was studied in healthy newborn infants. In this double-blind, placebo-controlled study, 109 newborn 1-month-old infants were assigned randomly to a probiotic group receiving a BB-12-containing tablet (n 55) or to...
Alternative Titles
Full title
Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_888092162
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_888092162
Other Identifiers
ISSN
0007-1145
E-ISSN
1475-2662
DOI
10.1017/S0007114510003685
